Literature DB >> 29055357

Inflammation in Dry Eye Disease: How Do We Break the Cycle?

Michelle K Rhee1, Francis S Mah2.   

Abstract

This article reviews the literature and summarizes the role of inflammation in dry eye disease. A PubMed search was performed using the keywords inflammatory cycle and dry eye. All searches were limited to articles published in or translated into the English language, dating from 1973 through March 2017. There were no restrictions on the study design. Advances in understanding the pathogenesis of dry eye disease has revealed that inflammation is a core driver: the so-called "vicious circle" of inflammation. Researchers continue to analyze the precise mechanisms by which inflammation occurs. This has led to therapeutic options to break the cycle. Continued animal and human studies reveal other potential sites for treatment in this complex host of disorders.
Copyright © 2017 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29055357     DOI: 10.1016/j.ophtha.2017.08.029

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

Review 1.  Immunity and pain in the eye: focus on the ocular surface.

Authors:  Romina Mayra Lasagni Vitar; Filippo Bonelli; Paolo Rama; Giulio Ferrari
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

2.  Neutrophil/Lymphocyte Ratio as an Inflammatory Predictor of Dry Eye Disease: A Case-Control Study.

Authors:  Yi-Fang Meng; Qi Pu; Qian Ma; Wei Zhu; Xin-Yu Li
Journal:  Ther Clin Risk Manag       Date:  2021-03-23       Impact factor: 2.423

3.  A new approach of ocular nebulization with vitamin B12 versus oxytocin for the treatment of dry eye disease: an in vivo confocal microscopy study.

Authors:  Jiarui Yang; Yushi Liu; Yanhui Xu; Xiaodan Li; Jiayu Fu; Xiaodan Jiang; Yilin Chou; Jiahui Ma; Ran Hao; Rong Zhang; Weiqiang Qiu; Xuemin Li
Journal:  Drug Des Devel Ther       Date:  2019-07-18       Impact factor: 4.162

Review 4.  Interplay between Oxidative Stress, Inflammation, and Amyloidosis in the Anterior Segment of the Eye; Its Pathological Implications.

Authors:  Roxanna Perez-Garmendia; Alicia Lopez de Eguileta Rodriguez; Ivan Ramos-Martinez; Nayeli Martínez Zuñiga; Roberto Gonzalez-Salinas; Hugo Quiroz-Mercado; Edgar Zenteno; Eleazar Ramírez Hernández; Luis Fernando Hernández-Zimbrón
Journal:  Oxid Med Cell Longev       Date:  2020-06-03       Impact factor: 6.543

5.  Effects of preoperative doses of betamethasone acetate 0.1% on dry eye control after cataract surgery.

Authors:  Saeed Shokoohi-Rad; Seyedeh Zeinab Hashemi Javaheri; Fatemeh Zare Malekabad; Hamid Khakshoor; Mohammad Khajeh Daluee
Journal:  Indian J Ophthalmol       Date:  2020-03       Impact factor: 1.848

6.  Chronic dry eye induced corneal hypersensitivity, neuroinflammatory responses, and synaptic plasticity in the mouse trigeminal brainstem.

Authors:  Darine Fakih; Zhanlin Zhao; Pierre Nicolle; Elodie Reboussin; Fanny Joubert; Jade Luzu; Antoine Labbé; William Rostène; Christophe Baudouin; Stéphane Mélik Parsadaniantz; Annabelle Réaux-Le Goazigo
Journal:  J Neuroinflammation       Date:  2019-12-17       Impact factor: 8.322

7.  hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye.

Authors:  Chaoqun Yu; Peng Chen; Jing Xu; Yaning Liu; Hui Li; Linna Wang; Guohu Di
Journal:  Sci Rep       Date:  2020-09-03       Impact factor: 4.379

8.  Once-Daily Topical Phosphosulindac Is Efficacious in the Treatment of Dry Eye Disease: Studies in Rabbit Models of Its Main Clinical Subtypes.

Authors:  Wei Huang; Liqun Huang; Wenyi Li; M Sait Saglam; Konstantinos Tourmouzis; Sanford M Goldstein; Adam Master; Robert Honkanen; Basil Rigas
Journal:  J Ocul Pharmacol Ther       Date:  2021-12-29       Impact factor: 2.671

Review 9.  Application of Animal Models in Interpreting Dry Eye Disease.

Authors:  Jun Zhu; Takenori Inomata; Kendrick Co Shih; Yuichi Okumura; Kenta Fujio; Tianxiang Huang; Ken Nagino; Yasutsugu Akasaki; Keiichi Fujimoto; Ai Yanagawa; Maria Miura; Akie Midorikawa-Inomata; Kunihiko Hirosawa; Mizu Kuwahara; Hurramhon Shokirova; Atsuko Eguchi; Yuki Morooka; Fang Chen; Akira Murakami
Journal:  Front Med (Lausanne)       Date:  2022-02-01

Review 10.  Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders.

Authors:  Lydia J Beeken; Darren S J Ting; Laura E Sidney
Journal:  Stem Cells Transl Med       Date:  2020-09-08       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.